Skip to main content
. 2014 Apr 30;10(1):82–88. doi: 10.3892/mmr.2014.2201

Table I.

Cell cycle distribution of P4 generation HUVECs following KDNC1-siRNA treatment for 72 h (n=3).

Percentage (%)

Groups G1 S G2/M
NT-siRNA 94.25±5.6 4.75±1.0 1.00±0.5
KNDC1-siRNA 85.78±4.5* 8.29±1.0* 5.93±1.0*

Data are presented as the mean ± standard deviation.

*

P<0.05 compared with NT-siRNA.

KNDC1, kinase noncatalytic C-lobe domain containing 1; HUVECs, human umbilical vein endothelial cells; P4, passage 4; NT-siRNA, non-targeting control pool; siRNA, small interfering RNA.